POST Online Media Lite Edition


Discovery Life Sciences appoints Shawn Levy chief scientific officer

Christian Fernsby |
Huntsville, Al., USA - Discovery Life Sciences, a biospecimen and biomarker specialists, announced the appointment of Shawn Levy as chief scientific officer.

Article continues below

In this role, Dr. Levy will coordinate and support development of the overall scientific strategy for the business and drive cross-functional collaboration to evaluate and operationalize new and innovative services and technologies to significantly advance new therapies supported by biomarker and companion diagnostic programs.

Dr. Levy joined Discovery in 2019 via its acquisition of the HudsonAlpha Institute for Biotechnology's Genomics Services Laboratory, which he founded and built into one of the world's premier gene sequencing and bioinformatics laboratories.

In his prior position as Chief Scientific Officer of Genomics, he established an industry-wide reputation for successfully helping manufacturers and researchers evaluate and optimize new leading technologies and methods to support scientific investigation.

Dr. Levy received his doctorate in biochemistry and completed a postdoctoral fellowship in genetics in 2000 at Emory University in Atlanta.